Nu Skin Enterprises
NUS
Nu Skin Enterprises (NUS) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.20
- EPS estimate
- $0.20
- EPS surprise
- +0.00%
- Revenue surprise
- −7.27%
- Revenue
- $320.1M
- Revenue estimate
- $345.2M
- Reported
- Aug 10, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 10, 2026 | $0.20 | $0.20 | +0.00% | $320.1M | SEC |
| Q1 2026 | May 7, 2026 | $0.15 | $0.14 | −6.67% | $320.6M | SEC |
| Q4 2025 | Feb 12, 2026 | $0.30 | $0.29 | −3.33% | $370.3M | SEC |
| Q3 2025 | Nov 6, 2025 | $0.30 | $0.34 | +13.33% | $364.2M | SEC |
| Q2 2025 | Aug 7, 2025 | $0.25 | $0.43 | +75.51% | $386.1M | SEC |
| Q1 2025 | May 8, 2025 | $0.13 | $0.23 | +75.57% | $364.5M | SEC |
| Q4 2024 | Feb 13, 2025 | $0.22 | $0.38 | +76.74% | $445.6M | SEC |
| Q3 2024 | Nov 7, 2024 | $0.20 | $0.17 | −13.53% | $430.1M | SEC |
| Q2 2024 | Aug 8, 2024 | $0.17 | $0.21 | +25.60% | $439.1M | SEC |
| Q1 2024 | May 8, 2024 | $0.05 | $0.09 | +81.45% | $417.3M | SEC |
| Q4 2023 | Feb 14, 2024 | −$0.03 | $0.37 | +1580.00% | $488.6M | SEC |
| Q3 2023 | Nov 1, 2023 | $0.64 | −$0.74 | −215.03% | $498.8M | SEC |
| Q2 2023 | Aug 1, 2023 | $0.53 | $0.54 | +1.26% | $500.3M | SEC |
| Q1 2023 | May 3, 2023 | $0.30 | $0.23 | −23.33% | $481.5M | SEC |
| Q4 2022 | Feb 15, 2023 | $0.44 | $1.15 | +159.42% | $522.3M | SEC |
| Q3 2022 | Nov 2, 2022 | $0.37 | −$0.51 | −237.84% | $537.8M | — |
| Q2 2022 | Aug 4, 2022 | $0.79 | $0.67 | −14.73% | $560.6M | — |
| Q1 2022 | May 4, 2022 | $0.72 | $0.76 | +5.56% | $604.9M | — |
| Q4 2021 | Feb 16, 2022 | $0.95 | −$0.18 | −118.99% | $673.4M | SEC |
| Q3 2021 | Nov 3, 2021 | $0.86 | $0.97 | +13.12% | $641.2M | — |
Quarterly revenue
Frequently asked questions
When did Nu Skin Enterprises (NUS) last report earnings?
Nu Skin Enterprises last reported on Aug 10, 2026, covering fiscal Q2 2026.
Did NUS beat earnings estimates?
Nu Skin Enterprises reported EPS of $0.20 for Q2 2026, in line with the $0.20 consensus estimate.
How much revenue did NUS report last quarter?
Nu Skin Enterprises reported $320.1M in revenue for Q2 2026, against a consensus estimate of $345.2M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.